PATENT CLAIM ANALYSIS

Application Number: 15911079
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
This invention relates to a pharmaceutical composition made of a clindamycin salt complexed with strongly acidic non-spherical resin particles, wherein predominantly all of the resin particles are less than 75 microns in diameter, to form clindamycin-resin complex, wherein in the clindamycin-resin complex provides for immediate release of the clindamycin in a target environment and at least one non-ionic excipient. In one embodiment, the inventive subject matter is an oral liquid pharmaceutical formulation made of a complex of clindamycin hydrochloride, a fractionated resin and excipients to stabilize the complex. The pharmaceutical formulation remains stable in deionized water until the dosage form reaches an ion-rich environment (stomach or intestine), there which the active ingredient clindamycin hydrochloride is released.

Claim (Index 6):
The pharmaceutical composition of  claim 1 , wherein the resin is a fractionated sodium polystyrene sulfonate resin, wherein between 75-90 percent of the resin particles are less than 75 microns and between 10-25 percent are between 75-150 microns.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.60759
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13947907', '13844584', '13844555', '13947881', '14661639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.702884186350409
- 35 USC 102 Novelty (BERT): 0.5054084798562948
- Combined Prediction Score: 0.6831366157009976
- Mean Citation Score: 230.39055
- Max Citation Score: 235.93529
- Similarity Product: 168.2351651033336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test